Status of work in July
AOTMiT begins work on the Ministry of Health’s orders in July:
- Tevimbra (tislelizumab) in the treatment of patients with lung cancer and pleural mesothelioma
- Rybrevant (amivantamab) in combination with Lazcluze (lazertinib) for the treatment of patients with lung cancer and pleural mesothelioma
The listed orders are available on the AOTMiT Public Information Bulletin.